Multi-modal Fusion Model and Deep Learning for Predicting Treatment Response in NKTCL

Inclusion Criteria

• •1\. Age ≥ 18 years.
• •2\. Pathologically confirmed extranodal natural killer/T-cell lymphoma (NKTCL) according to the World Health Organization (WHO) classification.
• •3\. Patients who are planned to receive first-line asparaginase-based chemotherapy or chemoradiotherapy.
• •4\. Patients who have either contrast-enhanced MRI of the nasopharynx obtained as part of routine clinical care or pretreatment whole-slide images (WSI) of tumor tissue from hematoxylin and eosin (H\&E)-stained sections available for analysis.
• •5\. Ability to understand the study and provide written informed consent (ICF).